BBTX

Bambusa Therapeutics, Inc. - Common stock (BBTX)

About Bambusa Therapeutics, Inc. - Common stock (BBTX)

Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases. The company was founded by Shan Shan Xu, Thang Ho, and Helmut Jeggle on March 14, 2024 and is headquartered in Boston, MA.

Details

Daily high

$16.75

Daily low

$15.23

Price at open

$16.20

52 Week High

$17.42

52 Week Low

$13.60

Market cap

128.7M

Dividend yield

Volume

314,745

Avg. volume

632,684

P/E ratio

Bambusa Therapeutics, Inc. - Common stock News